Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (81-90 of 481) with videos related to

Pageof 49
Sort By:
Gastrointestinal Endoscopy|February 24, 2020
High-flow nasal cannula oxygen therapy obscures severe respiration depression, providing an illusion of safetyAkira Horiuchi, David Y Graham
Helicobacter|July 5, 2012
Guide regarding choice of second-line therapy to obtain a high cumulative cure rateDavid Y Graham, Xavier Calvet
Gastrointestinal Endoscopy|August 24, 2019
Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020Mimi C Tan, David Y Graham
Journal of Gastroenterology and Hepatology|July 29, 2011
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot studyTaraq A Attumi, David Y Graham
Therapeutic Advances in Gastroenterology|December 25, 2010
A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcersSandy H Pang, David Y Graham
Gastroenterology & Hepatology|August 16, 2016
Rallying Community Health Care Providers to Close the Gap Between H pylori Guidelines and the Challenges of EradicationNeil H Stollman, David Y Graham
International Journal of Epidemiology|June 11, 2002
Commentary: What remains to be done regarding transmission of Helicobacter pyloriDavid Y Graham, Hoda M Malaty
Gastroenterology|August 2, 2003
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trialsDavid Y Graham, Maria Pina Dore
Gastroenterology|March 25, 2010
Obscure gastrointestinal bleeding: where do we go from here?Wai K Leung, David Y Graham
Journal of Hospital Medicine|July 30, 2021
Things We Do for No Reason™: Serum Serologic Helicobacter pylori TestingAnthony A Xu, David Y Graham
Pageof 49

Showing results (81-90 of 481) with videos related to

Sort By:
Pageof 49
Gastrointestinal Endoscopy|February 24, 2020
High-flow nasal cannula oxygen therapy obscures severe respiration depression, providing an illusion of safetyAkira Horiuchi, David Y Graham
Helicobacter|July 5, 2012
Guide regarding choice of second-line therapy to obtain a high cumulative cure rateDavid Y Graham, Xavier Calvet
Gastrointestinal Endoscopy|August 24, 2019
Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020Mimi C Tan, David Y Graham
Journal of Gastroenterology and Hepatology|July 29, 2011
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot studyTaraq A Attumi, David Y Graham
Therapeutic Advances in Gastroenterology|December 25, 2010
A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcersSandy H Pang, David Y Graham
Gastroenterology & Hepatology|August 16, 2016
Rallying Community Health Care Providers to Close the Gap Between H pylori Guidelines and the Challenges of EradicationNeil H Stollman, David Y Graham
International Journal of Epidemiology|June 11, 2002
Commentary: What remains to be done regarding transmission of Helicobacter pyloriDavid Y Graham, Hoda M Malaty
Gastroenterology|August 2, 2003
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trialsDavid Y Graham, Maria Pina Dore
Gastroenterology|March 25, 2010
Obscure gastrointestinal bleeding: where do we go from here?Wai K Leung, David Y Graham
Journal of Hospital Medicine|July 30, 2021
Things We Do for No Reason™: Serum Serologic Helicobacter pylori TestingAnthony A Xu, David Y Graham
Pageof 49